Compounds > aspirin
Page last updated: 2024-10-23

aspirin and Mucorales Infection

aspirin has been researched along with Mucorales Infection in 2 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Research Excerpts

ExcerptRelevanceReference
"Low dose aspirin improves survival rates in coronavirus disease 2019 associated mucormycosis."8.12Decreased mortality in coronavirus disease 2019 associated mucormycosis with aspirin use: a retrospective cohort study. ( Adhikari, A; Biswas, R; Chadaram, S; Chakraborty, S; Chenniappan, S; Chithambaram, KS; Das, KK; Hallur, VK; Karakkandy, V; Mishra, A; Mittal, Y; Nayak, A; Parida, PK; Pradhan, P; Preetam, C; Samal, DK; Sarkar, S; Shah, A; Shaikh, Z; Sharma, P; Swarup, A; Veeti, AK, 2022)
"Low dose aspirin improves survival rates in coronavirus disease 2019 associated mucormycosis."4.12Decreased mortality in coronavirus disease 2019 associated mucormycosis with aspirin use: a retrospective cohort study. ( Adhikari, A; Biswas, R; Chadaram, S; Chakraborty, S; Chenniappan, S; Chithambaram, KS; Das, KK; Hallur, VK; Karakkandy, V; Mishra, A; Mittal, Y; Nayak, A; Parida, PK; Pradhan, P; Preetam, C; Samal, DK; Sarkar, S; Shah, A; Shaikh, Z; Sharma, P; Swarup, A; Veeti, AK, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Shaikh, Z1
Sarkar, S1
Biswas, R1
Adhikari, A1
Hallur, VK1
Parida, PK1
Preetam, C1
Pradhan, P1
Samal, DK1
Nayak, A1
Chadaram, S1
Das, KK1
Chakraborty, S1
Sharma, P1
Veeti, AK1
Karakkandy, V1
Mishra, A1
Mittal, Y1
Chithambaram, KS1
Swarup, A1
Chenniappan, S1
Shah, A1
Leeuw, NJ1
Swart, CW1
Ncango, DM1
Kriel, WM1
Pohl, CH1
van Wyk, PW1
Kock, JL1

Other Studies

2 other studies available for aspirin and Mucorales Infection

ArticleYear
Decreased mortality in coronavirus disease 2019 associated mucormycosis with aspirin use: a retrospective cohort study.
    The Journal of laryngology and otology, 2022, Volume: 136, Issue:12

    Topics: Antifungal Agents; Aspirin; COVID-19; Debridement; Humans; Mucormycosis; Orbital Diseases; Retrospec

2022
Anti-inflammatory drugs selectively target sporangium development in Mucor.
    Canadian journal of microbiology, 2009, Volume: 55, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Aspirin; Benzoic Acid; Ibuprofe

2009